Ticker
PFE

Price
25.29
Stock movement down
-0.28 (-1.08%)
Company name
Pfizer Inc
Exchange
(NYSE
,
Currency
USD
)
Sector
Healthcare >
Drug Manufacturers - General
Market cap
143.28B
Ent value
271.10B
Price/Sales
2.60
Price/Book
1.55
Div yield
6.64%
Div growth
4.94%
Growth years
11
FCF payout
182.42%
Trailing P/E
-
Forward P/E
9.23
PEG
-
EPS growth
-27.60%
1 year return
-13.64%
3 year return
-22.67%
5 year return
-6.96%
10 year return
-1.53%
Last updated: 2024-12-04

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

BUSINESS INSIGHT

Segment Revenues ($M)

Loading...
Covid-19 vaccine comments

BNT162b2, which was granted an emergency use authorization (EUA) in the U.S. in December 2020, and which contributed $154 million in sales in the fourth quarter

Geographic Revenues ($M)

Loading...

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

DIVIDENDS

Dividend yield - 5y

Loading...
Dividend yield data
Dividend per share1.68
Dividend yield6.64%
Payout frequencyQuarterly
Maximum yield6.75%
Average yield4.32%
Minimum yield2.61%
Discount to avg yield34.94%
Upside potential53.71%
Yield as % of max yield98.38%

Yield distribution (inverse percentile) - 5y

Loading...
Yield distribution data
Dividend yield6.64%
Current yield distribution0.48%
Yield at 100% (Min)2.61%
Yield at 90%3.15%
Yield at 80%3.37%
Yield at 50% (Median)4.11%
Yield at 20%5.52%
Yield at 10%5.94%
Yield at 0% (Max)6.75%

Dividend per share

Loading...
Dividend per share data
Years of growth11 years
CCC statusDividend Contender
Dividend per share1.68
Payout frequencyQuarterly
Ex-div date8 Nov 2024
EPS (TTM)-0.05
EPS (1y forward)2.74
EPS growth (5y)-27.60%
EPS growth (5y forward)5.37%

Dividend growth

Loading...
Please create a free account or log in to access this chart
Dividend growth data
PFES&P500
DGR MR2.44%-0.74%
DGR TTM2.44%7.63%
DGR 3 years4.43%5.24%
DGR 5 years4.94%5.40%
DGR 10 years6.07%7.07%
DGR 15 years2.03%6.12%
Time since last change announced358 days
EPS growth (5y)-27.60%
EPS growth (5y forward)5.37%

Payout ratio

Loading...
Please create a free account or log in to access this chart
Payout ratio data
EPS coverageFCF coverage
TTM-3147.30%182.42%
Average--
Forward61.31%-

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF16.70
Price to FCF28.06
Price to EBITDA15.46
EV to EBITDA29.26

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales2.60
Price to Book1.55
EV to Sales4.92

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count5.67B
EPS (TTM)-0.05
FCF per share (TTM)0.90

Income statement

Loading...
Income statement data
Revenue (TTM)55.09B
Gross profit (TTM)28.28B
Operating income (TTM)1.97B
Net income (TTM)-296.00M
EPS (TTM)-0.05
EPS (1y forward)2.74

Margins

Loading...
Margins data
Gross margin (TTM)51.33%
Operating margin (TTM)3.58%
Profit margin (TTM)-0.54%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash719.00M
Net receivables10.99B
Total current assets42.41B
Goodwill69.30B
Intangible assets62.83B
Property, plant and equipment35.16B
Total assets221.09B
Accounts payable5.59B
Short/Current long term debt69.54B
Total current liabilities40.50B
Total liabilities128.54B
Shareholder's equity92.56B
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)8.58B
Capital expenditures (TTM)3.47B
Free cash flow (TTM)5.11B
Dividends paid (TTM)9.32B

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-0.32%
Return on Assets-0.13%
Return on Invested Capital-0.18%
Cash Return on Invested Capital3.17%

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open25.45
Daily high25.50
Daily low25.21
Daily Volume10.9M
All-time high61.25
1y analyst estimate31.46
Beta0.64
EPS (TTM)-0.05
Dividend per share1.68
Ex-div date8 Nov 2024
Next earnings date28 Jan 2025

Downside potential

Loading...
Downside potential data
PFES&P500
Current price drop from All-time high-58.72%-
Highest price drop-76.70%-56.47%
Date of highest drop2 Mar 20099 Mar 2009
Avg drop from high-30.84%-11.14%
Avg time to new high37 days12 days
Max time to new high5620 days1805 days

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
PFE (Pfizer Inc) company logo
Marketcap
143.28B
Marketcap category
Large-cap
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Employees
88000
SEC filings
CEO
Albert Bourla
Country
USA
City
New York
Stock type
Common stock
CCC status
Dividend Contender
Dividend Frequency
Quarterly
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...